Editorial

DOI: 10.4244/EIJ-E-24-00067

Myval transcatheter heart valve system: a new TAVI contender and remaining uncertainties

Stephan Windecker1, MD; Daijiro Tomii1, MD

Transcatheter aortic valve implantation (TAVI) has evolved into a transformative alternative to surgical aortic valve replacement (SAVR), supported by robust evidence from numerous randomised clinical trials across the spectrum of surgical risk, and features two landmark transcatheter heart valve (THV) devices: the balloon-expandable SAPIEN (Edwards Lifesciences) and the self-expanding CoreValve/Evolut (Medtronic) series. Against this solid evidence base, novel THV technologies are increasingly tested in head-to-head comparisons against these established balloon-expandable and self-expanding valve standards of care (Figure 1)12345. In the recently published LANDMARK trial, a novel balloon-expandable prosthesis, the Myval THV (Meril Life Sciences), was directly compared with contemporary THVs (SAPIEN and Evolut series)4. Of note, the Myval THV introduces a sizing strategy with 1.5 mm diameter increments between nominal device sizes, allowing for a more nuanced sizing strategy to match the aortic annulus compared to conventional devices with fixed 3.0 mm diameter increments. Out of 5,109 screened patients, 768 patients deemed eligible for all three devices were randomly assigned 1:1 to Myval (N=384) or to contemporary THVs (N=384) with subsequent stratification...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 2
Jan 20, 2025
Volume 21 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00064 Jan 6, 2025
Bringing order to chaos. Invasive functional assessment for all patients in the cath lab?
Zimmermann F and Pollio Benvenuto C
free
Trending articles
57.8

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
36.35

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
35.15

State-of-the-Art

10.4244/EIJ-D-23-00895 Apr 1, 2024
Percutaneous interventions for pulmonary embolism
Finocchiaro S et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved